Sean Maduck - Aug 9, 2022 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Officer
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Sean Maduck
Stock symbol
CORT
Transactions as of
Aug 9, 2022
Transactions value $
-$5,356
Form type
4
Date filed
8/11/2022, 05:15 PM
Previous filing
Jul 19, 2022
Next filing
Aug 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Options Exercise $384 +200 +0.5% $1.92* 40.2K Aug 9, 2022 Direct F1
transaction CORT Common Stock Sale -$5.74K -200 -0.5% $28.70 40K Aug 9, 2022 Direct F1
holding CORT Common Stock 10K Aug 9, 2022 See Footnote F2
holding CORT Common Stock 10K Aug 9, 2022 See Footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock option (right to buy) Options Exercise $0 -200 -1% $0.00 19.8K Aug 9, 2022 Common Stock 200 $1.92 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction.
F2 Represents the shares held by Duckhill Capital, LLC of which the reporting person is President and disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
F3 Represents the shares held by Sean and Molly Maduck Living Trust of which the reporting person is a co-trustee.
F4 Fully exercisable.

Remarks:

President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.